Mentioned in ?
References in periodicals archive ?
Clinical and Radioimaging Characteristics of Neurognathostomiasis and Intraocular Gnathostomiasis (Adapted from Katchanov J et al 7, and Pillai GS et al) Neurological CNS entry access for Clinical neurological & And ocular infective third stage ophthalmological syndromes (L3) larvae presentations Radiculomyelitis/ Intervertebral Radiculopathy; spinal Myeloencephalitis foramina along spinal syndrome (paraplegia, nerves & vessels neurogenic bladder, quadriplegia); may progress to myeloencephalitis.
MarquisA (ponazuril) Antiprotozoal Oral Paste, marketed in North America for over a decade, treats equine protozoal myeloencephalitis (EPM) a disease that affects the central nervous system in horses.
So your horse has just been diagnosed with Equine Protozoal Myeloencephalitis (EPM).
Genetic variation among isolates of Sarcocystis neurona, the agent of protozoal myeloencephalitis, as revealed by amplified fragment length polymorphism markers.
Interestingly, they are resistant to rabies, but are known to carry protozoal myeloencephalitis, a disease that is fatal to horses.
Neurognathostomiasis should be suspected in patients who have eosinophilic radiculomyelitis, myeloencephalitis or meningoencephalitis, and a history of travel to gnathostomiasis-endemic areas.
Sarcocystis neurona is a parasite responsible for Equine Protozoal Myeloencephalitis (EPM).
Food and Drug Administration (FDA) providing comments to the Company regarding its application for approval of nitazoxanide, a product for the treatment of equine protozoal myeloencephalitis (EPM).
Protozoa: Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis.
CHISELLING, a well-bred Grade 1 winner who was recently sold to South African interests for stud duty, has been grounded in Kentucky after being diagnosed with the neurological disease equine protozoal myeloencephalitis (EPM).
myeloencephalitis (EPM), the most commonly diagnosed neurological disease in horses.